These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29068268)

  • 21. The role of LasR active site amino acids in the interaction with the Acyl Homoserine Lactones (AHLs) analogues: A computational study.
    Ahumedo Monterrosa M; Galindo JF; Vergara Lorduy J; Alí-Torres J; Vivas-Reyes R
    J Mol Graph Model; 2019 Jan; 86():113-124. PubMed ID: 30352386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of activation mechanism and conformational stability of
    Sivanandam M; Manjula S; Kumaradhas P
    J Biomol Struct Dyn; 2019 Sep; 37(15):4006-4018. PubMed ID: 30301423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of 15-hydroxyprostaglandin dehydrogenase catalytic reaction mechanism by molecular dynamics simulations.
    Al-Najjar BO
    J Mol Graph Model; 2018 Mar; 80():190-196. PubMed ID: 29414038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
    Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M
    J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of potent inhibitor for matrix metalloproteinase-9 by pharmacophore based modeling and dynamics simulation studies.
    Kalva S; Azhagiya Singam ER; Rajapandian V; Saleena LM; Subramanian V
    J Mol Graph Model; 2014 Apr; 49():25-37. PubMed ID: 24473069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantum polarized ligand docking investigation to understand the significance of protonation states in histone deacetylase inhibitors.
    Kalyaanamoorthy S; Chen YP
    J Mol Graph Model; 2013 Jul; 44():44-53. PubMed ID: 23732305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.
    Nanjan P; Nambiar J; Nair BG; Banerji A
    Bioorg Med Chem; 2015 Jul; 23(13):3781-7. PubMed ID: 25907368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
    Venugopal PP; Das BK; Soorya E; Chakraborty D
    Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease.
    Gupta A; Jamal S; Goyal S; Jain R; Wahi D; Grover A
    BMC Bioinformatics; 2015; 16 Suppl 19(Suppl 19):S10. PubMed ID: 26695135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations.
    Shamim A; Abbasi SW; Azam SS
    J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxaprozin: A new hope in the modulation of matrix metalloproteinase 9 activity.
    Ianni A; Celenza G; Franceschini N
    Chem Biol Drug Des; 2019 May; 93(5):811-817. PubMed ID: 30582279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
    Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
    J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
    Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
    J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening approaches against claudin-4 focusing on therapeutics through molecular docking and the analysis of their relative dynamics: a theoretical approach.
    Rambabu M; Jayanthi S
    J Recept Signal Transduct Res; 2020 Oct; 40(5):436-441. PubMed ID: 32321343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8.
    Kalva S; Vinod D; Saleena LM
    J Mol Model; 2014 May; 20(5):2191. PubMed ID: 24756550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Dynamics Simulations of Matrix Metalloproteinase 13 and the Analysis of the Specificity Loop and the S1'-Site.
    Choi JY; Chung E
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural dynamics and quantum mechanical aspects of shikonin derivatives as CREBBP bromodomain inhibitors.
    Mitra S; Dash R
    J Mol Graph Model; 2018 Aug; 83():42-52. PubMed ID: 29758466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unravelling novel congeners from acetyllysine mimicking ligand targeting a lysine acetyltransferase PCAF bromodomain.
    Suryanarayanan V; Singh SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4303-4319. PubMed ID: 29228881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.